Comparison results
Results: Differences Similar | ✘Human papillomavirus | ✘Giant Bushke-Levenstein condyloma | |||||||
Related research | Analogs | Analogs | |||||||
| |||||||||
Distinctive symptoms | |||||||||
Register, to see more distinctive signs of diseases and studies | 60% | — | |||||||
Register, to see more distinctive signs of diseases and studies | — | 100% | |||||||
warts | 100% | 41% | |||||||
genital warts | 13% | 81% | |||||||
papillomas on the neck | 42% | — | |||||||
aggressive | — | 56% | |||||||
flat warts | 27% | — | |||||||
warts | 14% | 66% | |||||||
purulent plugs in the tonsils | 22% | — | |||||||
keratoacanthoma of the skin | — | 52% | |||||||
lot of moles | 22% | — | |||||||
scleroatrophic lichen | — | 50% | |||||||
ovarian cysts | 21% | — | |||||||
tumors of the rectum | — | 47% | |||||||
decreased libido | 17% | — | |||||||
warts are large | — | 42% | |||||||
endometriosis | 16% | — | |||||||
basal | — | 40% | |||||||
illness from stress | 15% | — | |||||||
carcinoid | — | 39% | |||||||
intestinal lethargy | 14% | — | |||||||
carcinoid tumors of the gastrointestinal tract | — | 39% | |||||||
time of year | 14% | — | |||||||
epithelioma | — | 39% | |||||||
hypotension | 13% | — | |||||||
oncology | 6% | 39% | |||||||
condylomas in the vagina | 9% | — | |||||||
ureaplasmosis | — | 33% | |||||||
condylomas in women | 9% | — | |||||||
secondary syphilis | — | 33% | |||||||
sexually transmitted diseases | 7% | — | |||||||
phimosis | — | 33% | |||||||
endocervicitis | 6% | — | |||||||
red lichen planus | — | 33% | |||||||
bleeding during pregnancy | 6% | — | |||||||
lymphosarcoma | — | 32% | |||||||
malignization | 6% | — | |||||||
-willed redness of the anus | — | 30% | |||||||
pregnancy | 6% | — | |||||||
sweating | — | 30% | |||||||
intra-phase infections | 5% | — | |||||||
multiple warts | — | 29% | |||||||
vulvovaginitis | 5% | — | |||||||
lichen | — | 28% | |||||||
intestinal mucosa | 5% | — | |||||||
primary-multiple tumors | — | 28% | |||||||
vulva infections | 5% | — | |||||||
STDs | 9% | 36% | |||||||
impaired uterine function | 5% | — | |||||||
diseases of the gastrointestinal tract | 4% | 31% | |||||||
female pelvic organs | 4% | — | |||||||
chlamydia | — | 27% | |||||||
bleeding | 4% | — | |||||||
consequences of operation | — | 26% | |||||||
onset of illness | 4% | — | |||||||
cancer | 7% | 33% | |||||||
inflammation | 4% | — | |||||||
skin problems | — | 25% | |||||||
genital warts | 11% | 36% | |||||||
rapid growth | — | 24% | |||||||
consequences of taking medications | — | 24% | |||||||
cytomegalovirus | — | 23% | |||||||
syphilis | — | 23% | |||||||
intestinal tumor | — | 22% | |||||||
genital neoplasms | 6% | 27% | |||||||
radiation therapy | — | 21% | |||||||
irradiation | — | 20% | |||||||
surgical infections | — | 19% | |||||||
consequences of infection | — | 18% |
Instructions
Video
|